| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |